Growing And Innovating As A CDMO Business
Rentschler CEO Frank Mathias Sheds Light On The Company’s Strategy For The 2020s
Executive Summary
Frank Mathias, CEO of Rentschler Biopharma, a contract development and manufacturing organization, talks to In Vivo about the company’s new corporate strategy and why he allowed 18 months to prepare that plan for delivery.